The current institutional shareholding score of Cartesian Therapeutics Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 27.21%, representing a quarter-over-quarter increase of 9.60%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.24% of shares outstanding, with 4.76% increase in holdings.